We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

29 hedge funds and large institutions have $30.6M invested in Global Cord Blood Corporation in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

12% more funds holding

Funds holding: 2629 (+3)

3% more capital invested

Capital invested by funds: $29.6M → $30.6M (+$1.03M)

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
12
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q3 2014 in Review

29 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2014, worth a combined $30.6M — up 3.5% from $29.6M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CO positions and 2 closed out — a net gain of 3 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Errol M. Rudman, opening a new position worth an estimated $1.67M. The largest seller was Cortex Capital Management, cutting an estimated $485K.

  • 29 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2014, up from 26 in Q2 2014.
  • Funds reported $30.6M of Global Cord Blood Corporation stock for Q3 2014, up 3.5% quarter-over-quarter.
  • 5 funds opened new Global Cord Blood Corporation positions in Q3 2014 and 2 closed out, a net change of +3 holders.
  • The largest Global Cord Blood Corporation buyer in Q3 2014 was Errol M. Rudman, an estimated $1.67M added.
  • The largest Global Cord Blood Corporation seller in Q3 2014 was Cortex Capital Management, an estimated $485K sold.

Based on aggregated 13F filings for Q3 2014.